This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Dec 6;328(21):2112-2113.

doi: 10.1001/jama.2022.21892.

How Much of an "Advantage" Is Medicare Advantage?

David J Meyers¹, Andrew M Ryan¹, Amal N Trivedi¹

Affiliations

PMID: 36472612
DOI: 10.1001/jama.2022.21892

Comment

How Much of an "Advantage" Is Medicare Advantage?

David J Meyers et al. JAMA. 2022.

. 2022 Dec 6;328(21):2112-2113.

doi: 10.1001/jama.2022.21892.

Authors

David J Meyers¹, Andrew M Ryan¹, Amal N Trivedi¹

Affiliation

¹ Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.

PMID: 36472612
DOI: 10.1001/jama.2022.21892

No abstract available

PubMed Disclaimer

Comment on

Association of Medicare Advantage vs Traditional Medicare With 30-Day Mortality Among Patients With Acute Myocardial Infarction.
Landon BE, Anderson TS, Curto VE, Cram P, Fu C, Weinreb G, Zaslavsky AM, Ayanian JZ. Landon BE, et al. JAMA. 2022 Dec 6;328(21):2126-2135. doi: 10.1001/jama.2022.20982. JAMA. 2022. PMID: 36472594 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems